CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Saved in:
Bibliographic Details
Title: CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.
Authors: Rocco JM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Oved JH; Pediatric Transplant and Cellular Therapy Service, Memorial Sloan Kettering Kids, Memorial Sloan Kettering Cancer Center, New York, NY., Patel RJ; Department of Medicine, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY., Herskovits AZ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Nair N; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Shakoory B; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Robertson TE; Medicine Institute, Allegheny Health Network, Pittsburgh, PA., Dileo R; Medicine Institute, Allegheny Health Network, Pittsburgh, PA., Jacobs MW; Medicine Institute, Allegheny Health Network, Pittsburgh, PA., Zerbe CS; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Gordon RA; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Ombrello MJ; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD., Ombrello AK; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Shah NN; National Cancer Institute, National Institutes of Health, Bethesda, MD., Dimitrova D; National Cancer Institute, National Institutes of Health, Bethesda, MD., Kanakry J; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Zelenetz AD; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Moskowitz AJ; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Stuver R; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Epstein-Peterson ZD; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ghione P; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Mead E; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shahid Z; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Human Pathology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Raj S; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Park JH; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Giralt SA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Maillard I; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Geyer MB; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Xiao W; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lim M; Department of Medicine, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY., Zwicker JI; Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Mones J; Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Parameswaran R; Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Banaszak L; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Geller S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Santomasso BD; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Neurology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shouval R; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Curran KJ; Pediatric Transplant and Cellular Therapy Service, Memorial Sloan Kettering Kids, Memorial Sloan Kettering Cancer Center, New York, NY., Delmonte O; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Notarangelo LD; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Cohen JI; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Holland SM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Salles G; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Horwitz SM; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Vardhana SA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Perales MA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Schwartz D; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Sereti I; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Johnson WT; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Blood [Blood] 2026 Feb 26; Vol. 147 (9), pp. 960-972.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2025030976